Sign In
Buy BAYRY
$9.92
+0.0400 (+0.405%)
At Close: Jun 03, 2026
Bayer Teams Up with Former Professional Quarterback Tony Romo on ‘Highlights REAL' Campaign
08:30am, Thursday, 29'th Jan 2026
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer Teams Up with Former Professional Quarterback Tony Romo on ‘Highlights REAL' Campaign.
Bayer Investing More Than $45M CAD to Build World-Class Canola Research and Development Facility in Canada
11:00am, Tuesday, 27'th Jan 2026
CALGARY, Alberta--(BUSINESS WIRE)--Bayer Crop Science today announced an unprecedented $45+ million CAD investment to strengthen Canada's leadership in canola innovation by establishing a cutting-edge
Bayer to Present Results From Phase III OCEANIC-STROKE Study of Asundexian in Secondary Stroke Prevention
07:30am, Tuesday, 27'th Jan 2026
BERLIN--(BUSINESS WIRE)--Bayer today announced that the main results from its global, landmark Phase III study OCEANIC-STROKE of asundexian in secondary stroke prevention, will be presented during two
Bayer Aktiengesellschaft (BAYRY) is a Top-Ranked Value Stock: Should You Buy?
10:41am, Monday, 26'th Jan 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Bayer Aktiengesellschaft (BAYRY) is a Strong Momentum Stock
10:51am, Friday, 23'rd Jan 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Bayer Aktiengesellschaft (BAYRY) is a Great Momentum Stock: Should You Buy?
01:00pm, Thursday, 22'nd Jan 2026
Does Bayer Aktiengesellschaft (BAYRY) have what it takes to be a top stock pick for momentum investors? Let's find out.
Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Receives Average Rating of “Buy” from Analysts
04:41am, Thursday, 22'nd Jan 2026
Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) has received a consensus rating of "Buy" from the seven research firms that are covering the company, MarketBeat Ratings reports. One equitie
Best Value Stocks to Buy for January 21st
06:31am, Wednesday, 21'st Jan 2026
BNPQY, BAYRY and DLAKY made it to the Zacks Rank #1 (Strong Buy) value stocks list on January 21, 2026.
New Strong Buy Stocks for January 21st
05:46am, Wednesday, 21'st Jan 2026
BAYRY, DAKT, ZTO, LRLCY and AVAH have been added to the Zacks Rank #1 (Strong Buy) List on January 21, 2026.
Bayer Shares Jump as Supreme Court Agrees to Review Key Roundup Case
09:40am, Tuesday, 20'th Jan 2026
BAYRY jumps 6.4% after the Supreme Court agrees to review the Durnell Roundup case, a key test of federal preemption in glyphosate litigation.
Bayer and Vanderbilt University Medical Center to Advance Treatments for Cardiovascular and Kidney Diseases
02:30am, Tuesday, 20'th Jan 2026
BERLIN & NASHVILLE, Tenn.--(BUSINESS WIRE)--Bayer and Vanderbilt University Medical Center (VUMC) today announced that they have entered a strategic five-year collaboration agreement to advance innova
Supreme Court to hear Bayer's appeal to block thousands of Roundup weedkiller lawsuits
06:27pm, Friday, 16'th Jan 2026
Bayer is arguing that consumers should not be able to sue it under state law for failing to warn that Roundup increases cancer risk because the Environmental Protection Agency has found no such risk
Market Today: Chips, energy and housing lead -- TSM, MU, NVO in focus
05:35pm, Friday, 16'th Jan 2026
Guru Stock PicksRichard Pzena has made the following transactions:Add in MBUU by 2.48%Stock News Stocks end flat as chips rally: Taiwan Semiconductor (TSM) and
Bayer welcomes the U.S. Supreme Court decision to review the Durnell case in the Roundup™ litigation
03:30pm, Friday, 16'th Jan 2026
LEVERKUSEN--(BUSINESS WIRE)--The U.S. Supreme Court today announced that it will review the Durnell Roundup™ case. Monsanto petitioned the court to hear Durnell in April 2025 and address the split i
Supreme Court to Hear Bayer's Challenge to Roundup Weedkiller Cases
03:02pm, Friday, 16'th Jan 2026
High court gives company hope in its effort to mitigate long-running litigation that has cost it billions of dollars.
